CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases
WEDNESDAY, Feb. 21, 2024 -- CD19 chimeric antigen receptor (CAR) T-cell therapy seems feasible, safe, and efficacious for patients with different autoimmune diseases, according to a study published in the Feb. 22 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2024 Category: Pharmaceuticals Source Type: news

Cushing Remission After Surgery May Raise Autoimmune Risk Cushing Remission After Surgery May Raise Autoimmune Risk
The findings suggested the need for closer postsurgical monitoring of patients with a family history of autoimmune disease.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 21, 2024 Category: Neurology Tags: Rheumatology Source Type: news

Incidence of Autoimmune Disease Increased After Surgical Remission of Cushing
TUESDAY, Feb. 20, 2024 -- Patients achieving surgical remission of Cushing disease (CD) have a higher incidence of autoimmune disease compared with those with nonfunctioning pituitary adenomas (NFPAs), according to a study published online Feb. 20... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2024 Category: Pharmaceuticals Source Type: news

Surgical Remission of Cushing's Disease Tied to New Autoimmune Conditions
(MedPage Today) -- Development of autoimmune disease was more common in patients with surgical remission of Cushing's disease than in those with surgically treated nonfunctioning pituitary adenomas (NFPAs), according to a retrospective matched... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - February 20, 2024 Category: Endocrinology Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2   Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16  February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news

Understanding sex differences in autoimmune disease
The activity of a type of RNA called Xist may help explain why autoimmune diseases are more common in women than men. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - February 12, 2024 Category: Consumer Health News Source Type: news

A Gen Xer moved from California to Colombia after overcoming a rare disease. The cost of living is much cheaper, and life is more peaceful
Andy Wiesmann and his wife met in Colombia. Andy Wiesmann Andy Wiesmann moved from California to Mexico to Colombia in search of a cheaper cost of living. He couldn't afford housing in California after developing a rare autoimmune disorder. He said Colombia has perfect weather, much lower costs,…#andywiesmann #colombia #mexico #medellín #goldenstate #census #censusbureau #acs #californians #middleeast (Source: Reuters: Health)
Source: Reuters: Health - February 10, 2024 Category: Consumer Health News Source Type: news

Why are autoimmune and allergic diseases rising?
In a Q&A, Yale ’s Andrew Wang discusses the increase in autoimmune and allergic diseases and the effects of the modern environment on our immune system. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 9, 2024 Category: Universities & Medical Training Source Type: news

$319 million IPO Kyverna sees shares soar on first day of trading
Kyverna is one of the early companies looking to expand cell therapy from cancer into larger autoimmune disease patient populations. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 9, 2024 Category: Biotechnology Authors: Ron Leuty Source Type: news

Comorbidities Weigh Heavily in Autoimmune Pregnancy Outcomes Comorbidities Weigh Heavily in Autoimmune Pregnancy Outcomes
After controlling for other chronic conditions, certain immune-mediated inflammatory diseases were not associated with an increased risk for poor pregnancy outcomes.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 7, 2024 Category: Dermatology Tags: Rheumatology Source Type: news

Preventing Autoimmune Diseases: New Vit. D, Omega-3 Findings Preventing Autoimmune Diseases: New Vit. D, Omega-3 Findings
Omega-3 fatty acid supplements prevented autoimmune diseases for 2 years after cessation, but vitamin D ' s effects tapered off, suggesting that continuous dosing is warranted.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 7, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today…#gaithersburg #neximmune #hcwainwrightco #forms3 #llc #430parkavenue #3rdfloor #section4a2 #securitiesact #aim (Source: Reuters: Health)
Source: Reuters: Health - February 6, 2024 Category: Consumer Health News Source Type: news

Lupus and Other Autoimmune Diseases Strike Far More Women Than Men. Now There ’ s a Clue Why
WASHINGTON — Women are far more likely than men to get autoimmune diseases, when an out-of-whack immune system attacks their own bodies — and new research may finally explain why. It’s all about how the body handles females’ extra X chromosome, Stanford University researchers reported Thursday — a finding that could lead to better ways to detect a long list of diseases that are hard to diagnose and treat. [time-brightcove not-tgx=”true”] “This transforms the way we think about this whole process of autoimmunity, especially the male-female bias,” said University o...
Source: TIME: Health - February 2, 2024 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized healthscienceclimate wire Source Type: news

Women Are More Prone to Autoimmune Disorders Than Men, and Scientists May Know Why
FRIDAY, Feb. 2, 2024 -- Women are much more prone than men to develop autoimmune diseases like rheumatoid arthritis, multiple sclerosis and lupus. Now, researchers have come up with a potential explanation for that -- one that ' s rooted in genes... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 2, 2024 Category: General Medicine Source Type: news